Political pressure and persistently high interest rates have some wondering if the industry’s model is broken.

This industry-leading move expands upon the company's existing collaboration with MEP 2040 to reduce carbon emissions and aligns with Trane Technologies' ambitious 2030 Sustainability Commitments.

Amid a raft of federal changes cutting funding and capacities at the Food and Drug Administration, investors are soon expected to pull back from the biotech industry, representing a blow to a ...

The three-year-old commission cited Chinese start-up BioMap as an example of the country’s efforts in AI-enabled biotech, noting its 100+ billion-parameter foundational model and an investment ...

Isomorphic will use the windfall to fund development of its next-generation artificial intelligence drug design model, the company announced in a March 31 release. The AI biotech is also looking ...

China is moving fast to dominate biotechnology, and the U.S. risks falling behind permanently unless it takes action over the next three years, a congressional commission said. Congress should ...

While researchers discovered IgE antibodies all the way back in 1966, and biologics pioneers considered them at the birth of the biotech industry, Epsilogen claims its candidate is the world’s ...

Once thought improbable, in vitro human models are demonstrating technological prowess in a growing range of applications.

NASDAQ-listed biopharmaceutical firm Atai Life Sciences says cryptocurrencies like Bitcoin could be key to survival for biotech startups ... added that the current industry approach is to put ...